China’s NHC Reports 2023 County Hospital Medical Service Capability Evaluation Results
The National Health Commission (NHC) of China has released a notice detailing the results of...
Policy / Regulatory
Yipinhong Pharmacy Repays $36.7 Million in Bromhexine Marketing Settlement
Yipinhong Pharmacy Co., Ltd (SHE: 300723), a China-based pharmaceutical company, has made a significant repayment...
China Unveils Comprehensive 2030 Plan to Combat Diabetes
China’s National Health Commission (NHC), in collaboration with 12 other ministries, has unveiled the ‘Health...
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...
China’s NMPA Suspends Daewoong Bio’s Antibiotic, Excludes Firm from National Procurement Program
The National Medical Products Administration (NMPA) in China has taken a decisive step to suspend...
China’s NHSA Updates DRG/DIP Payment Reform Program with New Exclusion Mechanisms and Timelines
The National Healthcare Security Administration (NHSA) in China has issued a notification outlining several updates...
WuXi AppTec Spends Over USD 360,000 on US Lobbying Amid Biosecure Act Deliberations
Endpoints News has reported that WuXi AppTec Co., Ltd, (SHA: 603259) a China-based Contract Development...
NMPA Suspends Import and Sale of SAMO S.p.A Knee and Hip Prosthesis Systems
The National Medical Products Administration (NMPA) has issued a notice to suspend the import, sale,...
China’s NMPA and NHC Implement New Rules for Temporary Import of Urgent Medical Devices
The National Medical Products Administration (NMPA) and the National Health Commission have issued the Management...
China Unveils Ambitious Healthcare Reforms at 20th Central Committee Plenary Session
The third plenary session of the 20th Central Committee of the Communist Party of China...
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome...
NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency
The National Healthcare Security Administration (NHSA) has issued a directive to standardize the procurement process...
Novo Nordisk Faces US Senators’ Scrutiny Over Levemir Withdrawal
US senators, including Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren, have voiced concerns over Novo...
U.S. Senate Passes Affordable Prescriptions for Patients Act to Limit Patent Thicketing
In a significant move to curb drug prices, the U.S. Senate unanimously passed the Affordable...
US House Speaker Mike Johnson Revives Possibility of Biosecure Act Vote
US House of Representatives Speaker Mike Johnson has suggested that a vote on the Biosecure...
China’s State Council Reportedly Approves Plan to Support Full Industry Chain of Innovative Drug Development
A State Council executive meeting, chaired by Chinese Premier Li Qiang, reportedly approved an “Implementation...
LEK Consulting’s Survey Reveals Biosecure Act’s Impact on Life Sciences Companies
LEK Consulting, a UK/US firm, has published the results of a global survey aimed at...
US Forms ‘Bio-5’ Coalition with Global Powers to Reduce Reliance on Chinese APIs
The White House announced last week a suite of new initiatives aimed at bolstering domestic...
China’s CDE Launches Pilot Program for Electronic Drug Registration Filings
The National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) in China has issued...
China’s NHSA Releases 2024 National Reimbursement Drug List Adjustment Plan
The National Healthcare Security Administration (NHSA) has published the National Reimbursement Drug List (2024) adjustment...